Leading Growth Driver in the Drugs for Immunotherapy Market in 2025: Rising Incidences Of Cancer In Drugs For Immunotherapy Market Driver's Influence

What Are the Market Size and Growth Forecast for the Drugs for Immunotherapy Market?
The market size for immunotherapy drugs has seen a swift expansion in the past years. Its growth trajectory from $255.14 billion in 2024 to an anticipated $281.43 billion in 2025 represents a compound annual growth rate (CAGR) of 10.3%. Various factors have spurred this growth during the historical period including an increased occurrence of cancer, unfulfilled medical requirements, awareness of cancer immunotherapy, a higher uptake of immunotherapeutic strategies, and substantial investment from leading pharmaceutical companies.

The immunotherapy drugs market is set for swift expansion in the upcoming years. The predicted growth will see it reach $445.12 billion by 2029, showcasing a compound annual growth rate (CAGR) of 12.1%. This anticipated growth within the forecast period is due to several factors such as the advent of combination therapies, the rise of personalized medicine, global expansion, the emergence of biomarker-driven therapies and the increase in clinical trials. Key trends predicting this growth trajectory include progress in immunology, development in car-t cell therapies, targeted immunotherapies, immunotherapy combinations, and neoantigen vaccines.

What Is Contributing to the Growth of the Drugs for Immunotherapy Market?
The upward trend in cancer occurrences worldwide is propelling the market for immunotherapy drugs. The principal reasons for many types of cancer are obesity, smoking, alcohol consumption, and unhealthy dietary habits. For example, Macmillan Cancer Support, the UK's largest healthcare charity, predicts that by 2025, the number of cancer patients will reach 3.5 million, increase to 4 million by 2030, and soar to 5.3 million by 2040. The most common cancer types are breast, lung, colon, rec*tum, and prostate. Factors contributing to around one-third of cancer-related deaths are tobacco use, high body mass index, alcohol consumption, a diet low in fruits and vegetables, and lack of exercise. The surge in cancer occurrences is anticipated to escalate the need for immunotherapy drugs, thereby boosting the growth of the immunotherapy drug market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2559&type=smp

Which Key Market Leaders Are Driving Drugs for Immunotherapy Industry Growth?
Major companies operating in the drugs for immunotherapy market include F. Hoffmann-La Roche Ltd., Novartis AG, Amgen Inc., AbbVie Inc., Merck & Co. Inc., GlaxoSmithKline plc, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, Johnson & Johnson, UbiVac, Pfizer Inc., Sanofi SA, Bayer AG, Celgene Corporation, Incyte Corporation, Juno Therapeutics Inc., Bluebird bio, Celldex Therapeutics, BeiGene, BioNTech AG, CytomX Therapeutics, Eisai Co. Ltd., Flexus Biosciences Inc., Genscript Biotech Corporation, Gilead Sciences Inc., Harpoon Therapeutics Inc., Heptares Therapeutics Ltd., Ignyta Inc., Immatics Biotechnologies, Jounce Therapeutics Inc.

What Are the Emerging Trends in the Drugs for Immunotherapy Industry?
Leading businesses in the immunotherapy drugs market are concentrating on the development of innovative products like Keytruda (pembrolizumab) to deliver trustworthy services to their customers. Keytruda (pembrolizumab) represents a form of immunotherapy that uses a targeted treatment drug known as an immune checkpoint inhibitor, designed for adult patients. For example, in January 2023, the US-based pharmaceutical corporation, Merck & Co., Inc., introduced Keytruda (pembrolizumab) which received clearance from the Food and Drug Administration, an American federal agency. This immunotherapy with Keytruda (pembrolizumab) is designated for the treatment of different types of cancer, aiding the immune system in its battle against cancer cells. The drug has been officially approved as a supplementary therapy for non-small cell lung cancer (NSCLC). This progression stands as a considerable stride in cancer therapy and is predicted to positively influence the healthcare sector.

What Are the Main Segments in the Drugs for Immunotherapy Market?
The drugs for immunotherapy market covered in this report is segmented -

1) By Type: Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types
2) By Therapy Area: Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas
3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Interferons: Interferon Alfa, Interferon Beta, Interferon Gamma
3) By Interleukins: Interleukin-2 (IL-2), Interleukin-6 (IL-6), Interleukin-12 (IL-12)
4) By Vaccines: Preventive Vaccines, Therapeutic Vaccines
5) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
6) By Other Types: Cancer Cell Therapies, Cytokine Therapy, T-Cell Receptor Therapy

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Which Geographic Area Leads the Drugs for Immunotherapy Market?
The countries covered in the drugs for immunotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Is Covered In The Drugs for Immunotherapy Global Market Report?

- Market Size Analysis: Analyze the Drugs for Immunotherapy Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Drugs for Immunotherapy Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Drugs for Immunotherapy Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Drugs for Immunotherapy Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2559

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.